Genomics and biological activity of neutrophil gelatinase-associated lipocalin in several clinical settings

Blood Purification

Volumn 35, Issue 1-3, 2013, Pages 139-143

  Virzì, Grazia Maria ^a,b   Clementi, Anna ^b,c   De Cal, Massimo ^a,b   Cruz, Dinna N ^a,b   Ronco, Claudio ^a,b  

^a SAN BORTOLO HOSPITAL   (Italy)

^b International Renal Research Institute Vicenza   (Italy)

^c SAN GIOVANNI DI DIO HOSPITAL   (Italy)

Author keywords

Acute kidney injury; Lipocalin; Neutrophil gelatinase associated protein; Siderophore

Indexed keywords

CREATININE; CYSTEINE; GELATINASE B; LIGAND; MESSENGER RNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SIDEROPHORE;

ACUTE KIDNEY FAILURE; ADIPOCYTE; APPENDICITIS; BACTERIAL INFECTION; BIOLOGICAL ACTIVITY; BODY FLUID; CARCINOGENESIS; CELL SURVIVAL; CLINICAL OBSERVATION; CONFERENCE PAPER; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; CROHN DISEASE; DIVERTICULITIS; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENOMICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IRON BINDING CAPACITY; KIDNEY CLEARANCE; KIDNEY ISCHEMIA; MACROPHAGE; MALIGNANT NEOPLASTIC DISEASE; MONOCYTE; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIODICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; SEPTIC SHOCK; STEADY STATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ULCERATIVE COLITIS; UPREGULATION; VIRUS INFECTION; ARTICLE; GENE INTERACTION; GENETIC ORGANIZATION; PROTEIN STRUCTURE;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; ADIPOCYTES; BIOLOGICAL MARKERS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INTESTINAL MUCOSA; LIGANDS; LIPOCALINS; MALE; MONOCYTES; NEUTROPHILS; PROSTATE; PROTO-ONCOGENE PROTEINS; RESPIRATORY MUCOSA; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 84874089801     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000346100     Document Type: Conference Paper

References (38)

1. Kjeldsen L, Cowland JB, Borregaard N: Human neutrophil gelatinase-associated lipo-calin and homologous proteins in rat and mouse. Biochim Biophys Acta 2000; 1482: 272-283.
2. Paragas N, Qiu A, Hollmen M, Nickolas TL, Devarajan P, Barasch J: NGAL-Siderocalin in kidney disease. Biochim Biophys Acta 2012; 1823: 1451-1458.
3. Flower DR, North AC, Sansom CE: The lipo-calin protein family: structural and sequence overview. Biochim Biophys Acta 2000; 1482: 9-24.
4. Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong R K: The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 2002; 10:1033-1043.
5. Ganfornina MD, Gutierrez G, Bastiani M, Sanchez D: A phylogenetic analysis of the li-pocalin protein family. Mol Biol Evol 2000; 17:114-126.
6. Flower DR: The lipocalin protein family: structure and function. Biochem J 1996; 318(Pt 1):1-14.
7. Chakraborty S, Kaur S, Guha S, Batra SK: The multifaceted roles of neutrophil gelatin-ase associated lipocalin (NGAL) in inflammation and cancer. Biochim Biophys Acta 2012; 1826: 129-169.
8. Holmes MA, Paulsene W, Jide X, Ratledge C, Strong RK: Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration. Structure 2005; 13: 29-41.
9. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N: Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993; 268:10425-10432.
10. Yang J, Moses MA: Lipocalin 2: a multifac-eted modulator of human cancer. Cell Cycle 2009; 8: 2347-2352.
11. Triebel S, Blaser J, Reinke H, Tschesche H: A 25-kDa alpha 2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase. FEBS Lett 1992; 314: 386-388.
12. Xu SY, Petersson CG, Carlson M, Venge P: The development of an assay for human neu-trophil lipocalin (HNL)-to be used as a specific marker of neutrophil activity in vivo and vitro. J Immunol Methods 1994; 171: 245-252.
13. Cai L, Rubin J, Han W, Venge P, Xu S: The origin of multiple molecular forms in urine of HNL/NGAL. Clin J Am Soc Nephrol 2010; 5:2229-2235.
14. Cowland JB, Borregaard N: The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules. J Leu-koc Biol 1999; 66:989-995.
15. Mori K, Nakao K: Neutrophil gelatinase-as-sociated lipocalin as the real-time indicator of active Kidney damage. Kidney Int 2007; 71: 967-970.
16. Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Mar-kowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D'Agati V, Devarajan P, Barasch J: Endocytic delivery of lipocalin-sidero-phore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005; 115:610-621.
17. Raymond KN, Dertz EA, Kim SS: Enterobac-tin: an archetype for microbial iron transport. Proc Natl Acad Sci USA 2003; 100: 3584-3588.
18. Barasch J, Mori K: Cell biology: iron thievery. Nature 2004; 432:811-813.
19. Takahashi M, Nakanishi H, Kawasaki S, Nishizawa NK, Mori S: Enhanced tolerance of rice to low iron availability in alkaline soils using barley nicotianamine amino-transferase genes. Nat Biotechnol 2001; 19: 466-469.
20. Borregaard N, Cowland JB: Neutrophil gela-tinase-associated lipocalin, a siderophore-binding eukaryotic protein. Biometals 2006; 19: 211-215.
21. Le Cabec V, Calafat J, Borregaard N: Sorting of the specific granule protein, NGAL, during granulocytic maturation of HL-60 cells. Blood 1997; 89:2113-2121.
22. Gwira JA, Wei F, Ishibe S, Ueland JM, Ba-rasch J, Cantley LG: Expression of neutro-phil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro. J Biol Chem 2005; 280:7875-7882.
23. Li JY, Ram G, Gast K, Chen X, Barasch K, Mori K, Schmidt-Ott K, Wang J, Kuo HC, Savage-Dunn C, Garrick MD, Barasch J: Detection of intracellular iron by its regulatory effect. Am J Physiol Cell Physiol 2004; 287:C1547-C1559.
24. Gazitt Y, Reddy SV, Alcantara O, Yang J, Boldt DH: A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate. J Cell Physiol 2001; 187: 124-135.
25. Ye Z, Connor JR: Screening of transcription-ally regulated genes following iron chelation in human astrocytoma cells. Biochem Bio-phys Res Commun 1999; 264:709-713.
26. Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Saito Y, Yoshioka T, Ogawa Y, Imamaki H, Kusakabe T, Ebihara K, Omata M, Satoh N, Sugawara A, Barasch J, Nakao K: Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int 2009; 75: 285-294.
27. Devireddy LR, Teodoro JG, Richard FA, Green MR: Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 2001; 293: 829-834.
28. Miharada K, Hiroyama T, Sudo K, Nagasawa T, Nakamura Y: Lipocalin 2 functions as a negative regulator of red blood cell production in an autocrine fashion. FASEB J 2005; 19: 1881-1883.
29. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A: Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004; 432:917-921.
30. Berger T, Togawa A, Duncan GS, Elia AJ, You-Ten A, Wakeham A, Fong HE, Cheung CC, Mak TW: Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion in-jur y. Proc Natl Acad Sci USA 2006; 103: 1834-1839.
31. Schmidt-Ott KM, Mori K, Li JY, Kalandadze A, Cohen DJ, Devarajan P, Barasch J: Dual action of neutrophil gelatinase-associated li-pocalin. J Am Soc Nephrol 2007; 18: 407-413.
32. Zhang Y, Fan Y, Mei Z: NGAL and NGALR overex pression i n huma n hepatocel lu la r carcinoma toward a molecular prognostic classification. Cancer Epidemiol 2012; 36:e294-e299.
33. Mishra J, Ma Q, Prada A, Mitsnefes M, Za-hedi K, Yang J, Barasch J, Devarajan P: Identification of neutrophil gelatinase-associat-ed lipocalin as a novel early urinary bio-marker for ischemic renal injury. J Am Soc Nephrol 2003; 14:2534-2543.
34. Mishra J, Mori K, Ma Q, Kelly C, Barasch J, Devarajan P: Neutrophil gelatinase-associ-ated lipocalin: a novel early urinary bio-marker for cisplatin nephrotoxicity. Am J Nephrol 2004; 24: 307-315.
35. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365:1231-1238.
36. Hirsch R, Dent C, Pfriem H, Allen J, Beekman RH 3rd, Ma Q, Dastrala S, Bennett M, Mitsnefes M, Devarajan P: NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol 2007; 22:2089-2095.
37. Wheeler DS, Devarajan P, Ma Q, Harmon K, Monaco M, Cvijanovich N, Wong HR: Serum neutrophil gelatinase-associated lipo-calin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med 2008; 36:1297-1303.
38. Zappitelli M, Washburn KK, Arikan AA, Loftis L, Ma Q, Devarajan P, Parikh CR, Goldstein SL: Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care 2007; 11:R84.